Profile data is unavailable for this security.
About the company
Novozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. The Company operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. It develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Bayer and Syngenta in Agriculture and DSM and Adisseo in Animal Health & Nutrition..
- Revenue in DKK (TTM)17.90bn
- Net income in DKK3.02bn
- Incorporated2000
- Employees6.40k
- LocationNovozymes A/SKrogshoejvej 36BAGSVAERD 2880DenmarkDNK
- Phone+45 44460000
- Fax+45 44469999
- Websitehttps://www.novozymes.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Azelis Group NV | 30.95bn | 1.32bn | 35.35bn | 4.21k | 26.17 | 1.83 | 16.33 | 1.14 | 0.743 | 0.743 | 17.29 | 10.62 | 0.7872 | 5.36 | 7.59 | 987,214.70 | 3.59 | 3.16 | 4.46 | 3.81 | 23.14 | 22.44 | 4.56 | 3.88 | 1.10 | 3.89 | 0.3989 | -- | 1.05 | -- | -16.65 | -- | -- | -- |
Clariant AG | 33.36bn | 1.28bn | 36.43bn | 10.48k | 28.36 | 2.35 | 10.67 | 1.09 | 0.5077 | 0.4043 | 13.28 | 6.14 | 0.7589 | 4.47 | 6.78 | 417,612.80 | 3.69 | 1.44 | 5.49 | 2.08 | 27.42 | 29.65 | 4.87 | 2.25 | 1.00 | 16.68 | 0.3823 | 397.72 | -15.79 | -0.1229 | 226.32 | -3.04 | -4.23 | -5.25 |
Oci NV | 7.59bn | -6.43bn | 39.48bn | 1.15k | -- | 6.10 | -- | 5.20 | -4.10 | -1.29 | 4.84 | 4.11 | 0.1132 | 4.94 | 2.00 | 888,855.50 | -6.24 | 1.31 | -12.54 | 2.10 | -31.26 | 16.86 | -55.11 | 3.28 | 1.55 | -2.55 | 0.5407 | -- | -47.15 | -9.61 | 10.45 | -- | 12.81 | -- |
Arkema SA | 69.56bn | 2.60bn | 52.45bn | 21.10k | 21.77 | 0.9057 | 6.45 | 0.754 | 4.31 | 4.31 | 119.47 | 103.51 | 0.6427 | 5.30 | 6.20 | 445,478.80 | 2.56 | 5.99 | 3.17 | 7.23 | 20.64 | 21.46 | 3.99 | 7.59 | 1.44 | 9.91 | 0.3489 | 31.72 | -17.63 | 1.54 | -57.64 | -9.82 | 2.78 | 6.96 |
Yara International ASA | 100.07bn | -260.54m | 54.21bn | 18.00k | -- | 1.07 | 8.00 | 0.5418 | -1.56 | -1.56 | 599.72 | 304.48 | 0.8763 | 3.27 | 7.34 | 8,486,911.00 | -0.1981 | 5.30 | -0.2548 | 6.97 | 22.84 | 26.69 | -0.2261 | 5.60 | 0.892 | 2.60 | 0.3659 | 94.60 | -35.44 | 3.60 | -98.27 | -21.30 | -2.76 | -8.10 |
Imcd NV | 33.12bn | 2.18bn | 59.22bn | 4.74k | 27.15 | 4.60 | 19.55 | 1.79 | 5.13 | 5.13 | 78.05 | 30.30 | 1.14 | 5.72 | 6.19 | 938,057.90 | 7.49 | 7.01 | 9.86 | 9.60 | 22.48 | 21.40 | 6.58 | 5.80 | 1.15 | 7.98 | 0.4932 | 44.25 | -3.45 | 13.30 | -6.65 | 23.91 | 24.09 | 22.87 |
Evonik Industries AG | 112.25bn | -2.65bn | 70.07bn | 33.09k | -- | 1.03 | 8.77 | 0.6242 | -0.7797 | -0.7797 | 32.52 | 19.61 | 0.7093 | 4.32 | 7.87 | 450,716.90 | -1.61 | 2.01 | -2.01 | 2.42 | 18.85 | 25.47 | -2.26 | 2.90 | 0.8772 | 10.34 | 0.3353 | 130.72 | -17.42 | 2.85 | -186.27 | -- | -3.51 | 0.3454 |
Brenntag SE | 121.44bn | 4.77bn | 71.02bn | 17.70k | 15.58 | 2.12 | 9.22 | 0.5848 | 4.24 | 4.24 | 107.52 | 31.08 | 1.50 | 8.00 | 6.30 | 919,905.10 | 5.96 | 6.40 | 8.66 | 9.02 | 24.30 | 23.03 | 3.98 | 4.02 | 1.14 | 14.89 | 0.3761 | 37.40 | -13.45 | 6.03 | -19.38 | 9.18 | 12.47 | -21.40 |
Syensqo SA | -745.47bn | -745.47bn | 72.16bn | 13.05k | -- | 1.25 | -- | -- | -- | -- | -- | 73.09 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.33 | -- | 0.2292 | -- | -13.02 | -- | -79.68 | -- | -- | -- |
Akzo Nobel NV | 79.40bn | 3.98bn | 81.59bn | 35.50k | 20.52 | 2.39 | 11.69 | 1.03 | 3.13 | 3.10 | 62.16 | 26.82 | 0.7352 | 3.49 | 3.91 | 302,585.20 | 3.98 | 4.15 | 6.50 | 6.06 | 40.74 | 40.51 | 5.42 | 6.07 | 0.7795 | 11.34 | 0.5161 | 63.75 | -1.64 | 2.88 | 23.48 | 2.25 | 12.32 | 1.41 |
Novozymes A/S | 17.90bn | 3.02bn | 169.39bn | 6.40k | 37.55 | 8.11 | 37.26 | 9.46 | 10.88 | 10.88 | 64.40 | 50.40 | 0.635 | 2.20 | 4.85 | 2,798,030.00 | 10.78 | 13.46 | 14.69 | 17.84 | 54.32 | 55.56 | 16.98 | 20.12 | 0.8035 | 38.91 | 0.3502 | 38.89 | 1.97 | 4.46 | -17.74 | -1.28 | 8.11 | 4.40 |
Data as of May 31 2024. Currency figures normalised to Novozymes A/S's reporting currency: Danish Krone DKK
Holder | Shares | % Held |
---|---|---|
The Vanguard Group, Inc.as of 09 May 2024 | 12.44m | 3.00% |
Norges Bank Investment Managementas of 31 Dec 2023 | 8.85m | 2.13% |
APG Asset Management NVas of 31 Dec 2022 | 7.67m | 1.85% |
BlackRock Fund Advisorsas of 09 May 2024 | 6.03m | 1.46% |
GuardCap Asset Management Ltd.as of 31 Mar 2024 | 5.23m | 1.26% |
Impax Asset Management Ltd.as of 30 Apr 2024 | 5.06m | 1.22% |
Handelsbanken Fonder ABas of 30 Apr 2024 | 4.42m | 1.07% |
MFS International (UK) Ltd.as of 30 Apr 2024 | 4.04m | 0.97% |
Baillie Gifford & Co.as of 30 Apr 2024 | 3.76m | 0.91% |
Pictet Asset Management SAas of 30 Apr 2024 | 3.26m | 0.79% |
More ▼
Data from 31 Dec 2023 - 30 Apr 2024Source: FactSet Research Systems Inc.